Harvard Health Law Perspectives 2008
“At least with drug samples, even if it is not the drug companies’ intention, they are easing the burden of prescription drug costs for some people. If the real concern is that samples are not available enough to those with the least access to them, look at connecting drug companies and/or physicians who receive the most samples to clinics and emergency departments. Do not sacrifice the mediocre in want of the perfect…”

http://www.law.uh.edu/healthlaw/perspectives/2008/(AK)%20Drug%20samples.pdf